AMCP

03/31/2026

Just in time for the end of MS Awareness month, Blair and Dallas Burleson, the founders of MS Looks Like Me, share their story with AMCP Unscripted.

In this episode of Unscripted, they join guest host Steve Kheloussi, PharmD, to share their MS journey: the years it took to get diagnosed, the daily reality of an unpredictable disease, and what caregivers carry that often goes unseen.

🎧 Listen now - https://hubs.li/Q048YrJw0

03/25/2026

AMCP Foundation is proud to honor Dr. William K. Fleming as the 2026 Steven G. Avey Award recipient.

Throughout more than 30 years in health care, Dr. Fleming has shaped the evolution of integrated, value‑based pharmacy and care delivery. A visionary leader and longtime champion of managed care pharmacy, Dr. Fleming has exhibited significant leadership skill and strength across his entire career with Humana.

We invite the managed care community to join us at as we celebrate his impact and leadership.

💙 Celebrate William: Support the Steven G. Avey Host Committee with a gift in his honor.
📅 Nominations reopen each May: Learn more about the award and how to recognize the next great leader.
🔗 https://hubs.li/Q048m_rL0

03/25/2026

AMCP 2026 is shaping up to be our biggest meeting this decade, and Nashville is the place to be April 13–16.
The leading voices and decision-makers in managed care will be in the room.

Will you?

Claim your spot → https://amcpannual.org/register

03/23/2026

The FDA has approved IMCIVREE® (setmelanotide) from AMCP member Rhythm Pharmaceuticals for patients living with acquired hypothalamic obesity (HO), expanding treatment options for this rare and complex condition.

Acquired HO is a rare disease characterized by accelerated and sustained weight gain caused by an injury to the hypothalamus or hypothalamic dysfunction.

With this label expansion, IMCIVREE is indicated to reduce excess body weight and maintain reduction long term in adults and pediatric patients aged 4 years and older with acquired HO.

Managed care and payer teams will play a critical role in translating this approval into access and support for patients and families.

Read the full press release to learn more about the indication, TRANSCEND trial data, and safety information: https://hubs.li/Q047N7Bc0

03/20/2026

Happy Patient Experience Data Friday! Here is another Myth vs Fact on Patient Voice in Health Care Decision-Making.

AMCP’s new resource “Guidance for Payers: Incorporating the Patient Voice into Formulary Decision- Making”, written by Steven Kheloussi, PharmD, MBA, FAMCP turns talk into action, offering a playbook on how to incorporate patient experience data (PED) and related info into your decision-making process.

Access the report here: https://hubs.li/Q041yWNZ0

03/20/2026

Looking for a reset during AMCP 2026? Take a short break and refocus.

Join the Zen Pool LEGO® Workshop, a 45 minute guided creativity session led by Kim Westrich, Registered Yoga Teacher (RYT-200) and Certified “Healthy Deviant” Life Coach. Using Silent Disco headphones and a custom LEGO® kit, you will step away from the noise of the meeting and build your own mini Zen Pool. It is a calm, hands-on pause that can help you clear your head before you head back into sessions.

Tuesday, April 14, 2026
4:30 to 5:15 p.m. | Exhibit Hall
Capacity is limited to 50 attendees.

Interested? Save your spot by adding the Zen Pool LEGO® to your registration. Your $35 contribution supports AMCP Foundation’s fundraiser: https://hubs.li/Q047HHTQ0" https://hubs.li/Q047HHTQ0

03/19/2026

AMCP has opened the public comment period for the Format for Formulary Submissions, Version 6.0.

AMCP is proposing updates to continue to support the exchange of clinical and economic evidence between manufacturers and health care decision-makers to inform formulary and coverage decisions.

The key areas of focus include:
- Biosimilars
- Gene and Cell Therapies
- Economic Value

Your input will help shape the Format v6.0. Comments are being accepted through April 22, 2026.

Review the proposed revisions and submit your comments: https://hubs.li/Q047zKBJ0

03/17/2026

📢 Call for Papers!

AMCP Foundation and JMCP are looking for innovative research that helps reduce health disparities in managed care pharmacy.

Up to two winning papers will receive a $10,000 award and be featured at the AMCP Foundation Symposium on Health Disparities in December 2026. Winning manuscripts will also be published in JMCP.

We welcome submissions from students, researchers, and professionals across all healthcare settings. (Pharmaceutical company employees may submit but are not eligible for award money.)

📅 Deadline: July 1, 2026

If you're working to make health care more equitable, we encourage you to apply!

👉 Learn more & submit: https://www.jmcp.org/authors-reviewers/call-for-papers

03/16/2026

If you rely on Medicaid, you shouldn’t have to pay for treatments that don’t work. The House of Representatives reintroduced the bipartisan Medicaid VBPs for Patients (MVP) Act, which would modernize Medicaid’s framework for value-based purchasing arrangements.

By allowing states to tie payment for high-cost therapies to how well they work for patients, the MVP Act helps:

- Expand access to cell and gene therapies and other cutting-edge treatments for people with rare diseases
- Protect state Medicaid programs and taxpayers from paying for treatments that are not effective
- Support sustainable innovation in the biopharmaceutical pipeline

Tell Congress to support the MVP Act! https://hubs.li/Q046_9ZH0

03/13/2026

Jessica spent years trying to understand what was happening with her health. When she finally learned she was living with EOE, she also discovered how challenging it could be to reach the treatments she needs.

Her story shines a light on what many patients experience: the long wait for answers, the emotional toll of uncertainty, and the obstacles that can stand between a diagnosis and the medication that truly helps.

Watch Jessica share her journey: https://hubs.li/Q046NHZH0

Sponsored by Takeda.

In this video, Jessica of Chadds Ford, Pennsylvania, shares her journey living with eosinophilic esophagitis (EOE), a chronic inflammatory condition that causes difficulty swallowing and food impactions. After years of symptoms that were initially treated as acid reflux, a biopsy finally confirmed h...

03/13/2026

Happy Patient Experience Data Friday! Here is another Myth vs Fact on Patient Voice in Health Care Decision-Making.

AMCP’s new resource “Guidance for Payers: Incorporating the Patient Voice into Formulary Decision- Making”, written by Steven Kheloussi, PharmD, MBA, FAMCP turns talk into action, offering a playbook on how to incorporate patient experience data (PED) and related info into your decision-making process.

Access the report here: https://hubs.li/Q041yPmn0

03/06/2026

Happy Patient Experience Data Friday! Here is another Myth vs Fact on Patient Voice in Health Care Decision-Making.

AMCP’s new resource “Guidance for Payers: Incorporating the Patient Voice into Formulary Decision- Making”, written by Steven Kheloussi, PharmD, MBA, FAMCP turns talk into action, offering a playbook on how to incorporate patient experience data (PED) and related info into your decision-making process.

Access the report here: https://hubs.li/Q041yMKn0